| |
| |
|
| Insider
Information: |
Debethizy J Donald |
| Relationship: |
President and CEO, Dir... |
| City: |
Winston-Salem |
| State: |
NC |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
798 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$408 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
798 |
|
|
| Total
Value |
$408 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Gyre Therapeutics |
GYRE |
President and CEO, Dir... |
2012-02-14 |
798 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GYRE |
Gyre Therapeutics |
President and CEO |
• • – |
2012-02-14 |
4 |
OE |
$5.10 |
$4,070 |
D/D |
798 |
798 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
President and CEO |
• • – |
2009-12-16 |
4 |
S |
$21.98 |
$5,230,437 |
D/D |
(237,930) |
0 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
President and CEO |
• • – |
2009-12-16 |
4 |
OE |
$1.75 |
$377,772 |
D/D |
209,004 |
237,930 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
President and CEO |
• • – |
2009-12-15 |
4 |
S |
$22.28 |
$342,922 |
D/D |
(15,391) |
28,926 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
President and CEO |
• • – |
2009-12-14 |
4 |
S |
$22.44 |
$58,340 |
D/D |
(2,600) |
44,317 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
President and CEO |
• • – |
2009-09-08 |
4 |
OE |
$1.75 |
$1,489 |
D/D |
851 |
47,768 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
President and CEO |
• • – |
2009-09-08 |
4 |
S |
$15.00 |
$12,765 |
D/D |
(851) |
46,917 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
President and CEO |
• • – |
2009-09-04 |
4 |
S |
$15.02 |
$167,474 |
D/D |
(11,149) |
46,917 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
President and CEO |
• • – |
2009-09-04 |
4 |
OE |
$1.75 |
$19,511 |
D/D |
11,149 |
58,066 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
President and CEO |
• • – |
2009-08-07 |
4 |
S |
$12.02 |
$68,555 |
D/D |
(5,700) |
46,917 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
President and CEO |
• • – |
2009-08-07 |
4 |
OE |
$1.75 |
$9,975 |
D/D |
5,700 |
52,617 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
President and CEO |
• • – |
2009-07-29 |
4 |
S |
$11.05 |
$64,218 |
D/D |
(5,700) |
46,917 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
President and CEO |
• • – |
2009-07-29 |
4 |
OE |
$1.75 |
$9,975 |
D/D |
5,700 |
52,617 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
President and CEO |
• • – |
2009-07-28 |
4 |
S |
$11.01 |
$28,616 |
D/D |
(2,600) |
46,917 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
President and CEO |
• • – |
2009-07-28 |
4 |
OE |
$1.75 |
$4,550 |
D/D |
2,600 |
49,517 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
President and CEO |
• • – |
2008-08-19 |
4 |
S |
$10.00 |
$17,000 |
D/D |
(1,700) |
93,835 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
President and CEO |
• • – |
2008-08-19 |
4 |
OE |
$1.75 |
$2,975 |
D/D |
1,700 |
95,535 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
President and CEO |
• • – |
2008-08-18 |
4 |
S |
$10.01 |
$9,010 |
D/D |
(900) |
93,835 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
President and CEO |
• • – |
2008-08-18 |
4 |
OE |
$1.75 |
$1,575 |
D/D |
900 |
94,735 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
President and CEO |
• • – |
2008-08-15 |
4 |
OE |
$1.75 |
$175 |
D/D |
100 |
93,935 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
President and CEO |
• • – |
2008-08-15 |
4 |
S |
$10.00 |
$1,000 |
D/D |
(100) |
93,835 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
President and CEO |
• • – |
2008-08-14 |
4 |
S |
$10.00 |
$14,730 |
D/D |
(1,473) |
93,835 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
President and CEO |
• • – |
2008-08-14 |
4 |
OE |
$1.75 |
$2,578 |
D/D |
1,473 |
95,308 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
President and CEO |
• • – |
2008-08-13 |
4 |
S |
$10.00 |
$23,240 |
D/D |
(2,324) |
93,835 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
President and CEO |
• • – |
2008-08-13 |
4 |
OE |
$1.75 |
$4,067 |
D/D |
2,324 |
96,159 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
